Combination of MEK1/2 inhibitor and LXR ligand synergistically inhibit atherosclerosis in LDLR deficient mice. Yang J, Liu L, Yang X, Duan Y, et al. Biochem Biophys Res Commun 2020;522:512-517.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Yang J, Liu L, Yang X, Duan Y, et al. Combination of MEK1/2 inhibitor and LXR ligand synergistically inhibit atherosclerosis in LDLR deficient mice. Biochem Biophys Res Commun 2020;522:512-517.
PMID: 31784089